Medibank Private (MPL.AX) Stock Price
Medibank Private Price
Revenue has compounded at 4.8% per year over the past 16 years to 8.16 B AUD. Earnings per share have grown at 11.2% per year over the last 16 years. Medibank Private's net margin stands at 6.1%, broadly stable from 6.3% several years earlier. Medibank Private currently offers a dividend yield of about 5.02%. The payout ratio is around 141% of earnings. The dividend has grown at 13.0% per year over the past 10 years. Analysts set a median price target of 5.00 AUD, implying 2.4% below the current price. Of 14 analysts, 5 rate the stock a buy — an overall Hold consensus. The stock trades about 24% above its 52-week low.
Medibank Private stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Medibank Private over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Medibank Private stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Medibank Private's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Medibank Private Price |
|---|---|
| 7/24/2026 | 5.12 AUD |
| 7/23/2026 | 5.11 AUD |
| 7/22/2026 | 5.11 AUD |
| 7/21/2026 | 5.14 AUD |
| 7/20/2026 | 5.13 AUD |
| 7/17/2026 | 5.13 AUD |
| 7/16/2026 | 5.06 AUD |
| 7/15/2026 | 5.07 AUD |
| 7/14/2026 | 5.07 AUD |
| 7/13/2026 | 5.09 AUD |
| 7/10/2026 | 5.05 AUD |
| 7/9/2026 | 5.04 AUD |
| 7/8/2026 | 5.05 AUD |
| 7/7/2026 | 5.00 AUD |
| 7/6/2026 | 4.97 AUD |
| 7/3/2026 | 5.00 AUD |
| 7/2/2026 | 4.95 AUD |
| 7/1/2026 | 4.95 AUD |
| 6/30/2026 | 5.01 AUD |
| 6/29/2026 | 4.98 AUD |
| 6/26/2026 | 4.92 AUD |
| 6/25/2026 | 4.97 AUD |
| 6/24/2026 | 4.88 AUD |
| 6/23/2026 | 4.90 AUD |
| 6/22/2026 | 4.91 AUD |
| 6/19/2026 | 4.88 AUD |
| 6/18/2026 | 4.88 AUD |
| 6/17/2026 | 4.86 AUD |
| 6/16/2026 | 4.86 AUD |
| 6/15/2026 | 4.86 AUD |
| 6/12/2026 | 5.00 AUD |
| 6/11/2026 | 4.93 AUD |
| 6/10/2026 | 4.84 AUD |
| 6/9/2026 | 4.84 AUD |
| 6/5/2026 | 4.77 AUD |
| 6/4/2026 | 4.68 AUD |
| 6/3/2026 | 4.67 AUD |
| 6/2/2026 | 4.69 AUD |
| 6/1/2026 | 4.74 AUD |
| 5/29/2026 | 4.80 AUD |
| 5/28/2026 | 4.81 AUD |
| 5/27/2026 | 4.84 AUD |
| 5/26/2026 | 4.78 AUD |
| 5/25/2026 | 4.84 AUD |
| 5/22/2026 | 4.82 AUD |
| 5/21/2026 | 4.84 AUD |
| 5/20/2026 | 4.80 AUD |
| 5/19/2026 | 4.79 AUD |
| 5/18/2026 | 4.69 AUD |
| 5/15/2026 | 4.66 AUD |
| 5/14/2026 | 4.59 AUD |
| 5/13/2026 | 4.56 AUD |
| 5/12/2026 | 4.53 AUD |
| 5/11/2026 | 4.57 AUD |
| 5/8/2026 | 4.59 AUD |
| 5/7/2026 | 4.60 AUD |
| 5/6/2026 | 4.66 AUD |
| 5/5/2026 | 4.65 AUD |
| 5/4/2026 | 4.73 AUD |
| 5/1/2026 | 4.72 AUD |
| 4/30/2026 | 4.69 AUD |
| 4/29/2026 | 4.61 AUD |
| 4/28/2026 | 4.54 AUD |
| 4/27/2026 | 4.60 AUD |
| 4/24/2026 | 4.65 AUD |
| 4/23/2026 | 4.57 AUD |
| 4/22/2026 | 4.71 AUD |
| 4/21/2026 | 4.67 AUD |
| 4/20/2026 | 4.66 AUD |
| 4/17/2026 | 4.67 AUD |
| 4/16/2026 | 4.66 AUD |
| 4/15/2026 | 4.65 AUD |
| 4/14/2026 | 4.55 AUD |
| 4/13/2026 | 4.52 AUD |
| 4/10/2026 | 4.52 AUD |
| 4/9/2026 | 4.45 AUD |
| 4/8/2026 | 4.42 AUD |
| 4/7/2026 | 4.44 AUD |
| 4/2/2026 | 4.43 AUD |
| 3/27/2026 | 4.41 AUD |
| 3/26/2026 | 4.46 AUD |
| 3/25/2026 | 4.48 AUD |
| 3/24/2026 | 4.39 AUD |
| 3/23/2026 | 4.31 AUD |
| 3/20/2026 | 4.25 AUD |
| 3/19/2026 | 4.33 AUD |
| 3/18/2026 | 4.29 AUD |
| 3/17/2026 | 4.28 AUD |
| 3/16/2026 | 4.28 AUD |
| 3/13/2026 | 4.25 AUD |
| 3/12/2026 | 4.12 AUD |
| 3/11/2026 | 4.16 AUD |
| 3/9/2026 | 4.18 AUD |
| 3/6/2026 | 4.29 AUD |
| 3/5/2026 | 4.32 AUD |
| 2/26/2026 | 4.38 AUD |
| 2/25/2026 | 4.42 AUD |
| 2/24/2026 | 4.41 AUD |
| 2/23/2026 | 4.45 AUD |
| 2/20/2026 | 4.47 AUD |
| 2/19/2026 | 4.52 AUD |
| 2/18/2026 | 4.82 AUD |
| 2/17/2026 | 4.52 AUD |
| 2/16/2026 | 4.49 AUD |
| 2/13/2026 | 4.47 AUD |
| 2/12/2026 | 4.47 AUD |
| 2/11/2026 | 4.57 AUD |
| 2/10/2026 | 4.56 AUD |
| 2/9/2026 | 4.59 AUD |
| 2/6/2026 | 4.57 AUD |
| 2/5/2026 | 4.60 AUD |
| 2/4/2026 | 4.60 AUD |
| 2/3/2026 | 4.65 AUD |
| 2/2/2026 | 4.65 AUD |
| 1/30/2026 | 4.61 AUD |
| 1/29/2026 | 4.61 AUD |
| 1/28/2026 | 4.63 AUD |
| 1/27/2026 | 4.56 AUD |
| 1/23/2026 | 4.55 AUD |
| 1/22/2026 | 4.62 AUD |
| 1/21/2026 | 4.70 AUD |
| 1/20/2026 | 4.64 AUD |
| 1/19/2026 | 4.67 AUD |
| 1/16/2026 | 4.66 AUD |
| 1/15/2026 | 4.71 AUD |
| 1/14/2026 | 4.72 AUD |
| 1/13/2026 | 4.75 AUD |
| 1/12/2026 | 4.73 AUD |
| 1/9/2026 | 4.83 AUD |
| 1/8/2026 | 4.79 AUD |
| 1/7/2026 | 4.75 AUD |
| 1/6/2026 | 4.68 AUD |
| 1/5/2026 | 4.76 AUD |
| 1/2/2026 | 4.82 AUD |
| 12/31/2025 | 4.80 AUD |
| 12/30/2025 | 4.81 AUD |
| 12/29/2025 | 4.76 AUD |
| 12/24/2025 | 4.77 AUD |
| 12/23/2025 | 4.83 AUD |
| 12/22/2025 | 4.78 AUD |
| 12/19/2025 | 4.78 AUD |
| 12/18/2025 | 4.78 AUD |
| 12/17/2025 | 4.78 AUD |
| 12/16/2025 | 4.80 AUD |
| 12/15/2025 | 4.77 AUD |
| 12/12/2025 | 4.68 AUD |
| 12/11/2025 | 4.65 AUD |
| 12/10/2025 | 4.66 AUD |
| 12/9/2025 | 4.65 AUD |
| 12/8/2025 | 4.53 AUD |
| 12/5/2025 | 4.48 AUD |
| 12/4/2025 | 4.52 AUD |
| 12/3/2025 | 4.61 AUD |
| 12/2/2025 | 4.64 AUD |
| 12/1/2025 | 4.68 AUD |
| 11/28/2025 | 4.75 AUD |
| 11/27/2025 | 4.78 AUD |
| 11/26/2025 | 4.79 AUD |
| 11/25/2025 | 4.73 AUD |
| 11/24/2025 | 4.86 AUD |
| 11/21/2025 | 4.73 AUD |
| 11/20/2025 | 4.79 AUD |
| 11/19/2025 | 4.79 AUD |
| 11/18/2025 | 4.81 AUD |
| 11/17/2025 | 4.87 AUD |
| 11/14/2025 | 4.87 AUD |
| 11/13/2025 | 4.85 AUD |
| 11/12/2025 | 5.03 AUD |
| 11/11/2025 | 5.01 AUD |
| 11/10/2025 | 4.97 AUD |
| 11/7/2025 | 4.95 AUD |
| 11/6/2025 | 4.98 AUD |
| 11/5/2025 | 4.90 AUD |
| 11/4/2025 | 4.84 AUD |
| 11/3/2025 | 4.89 AUD |
| 10/31/2025 | 4.88 AUD |
| 10/30/2025 | 4.86 AUD |
| 10/29/2025 | 4.84 AUD |
| 10/28/2025 | 4.90 AUD |
| 10/27/2025 | 4.80 AUD |
| 10/24/2025 | 4.78 AUD |
| 10/23/2025 | 4.77 AUD |
| 10/22/2025 | 4.70 AUD |
| 10/21/2025 | 4.71 AUD |
| 10/20/2025 | 4.70 AUD |
| 10/17/2025 | 4.67 AUD |
| 10/16/2025 | 4.79 AUD |
| 10/15/2025 | 4.75 AUD |
| 10/14/2025 | 4.73 AUD |
| 10/13/2025 | 4.79 AUD |
| 10/10/2025 | 4.83 AUD |
| 10/9/2025 | 4.79 AUD |
| 10/8/2025 | 4.81 AUD |
| 10/7/2025 | 4.82 AUD |
| 10/6/2025 | 4.83 AUD |
| 10/3/2025 | 4.82 AUD |
| 10/2/2025 | 4.87 AUD |
| 10/1/2025 | 4.86 AUD |
| 9/30/2025 | 4.82 AUD |
| 9/29/2025 | 4.86 AUD |
| 9/26/2025 | 4.81 AUD |
| 9/25/2025 | 4.76 AUD |
| 9/24/2025 | 4.83 AUD |
| 9/23/2025 | 4.86 AUD |
| 9/22/2025 | 4.85 AUD |
| 9/19/2025 | 4.89 AUD |
| 9/17/2025 | 4.87 AUD |
| 9/16/2025 | 4.88 AUD |
| 9/15/2025 | 4.86 AUD |
| 9/12/2025 | 4.87 AUD |
| 9/11/2025 | 4.85 AUD |
| 9/10/2025 | 4.92 AUD |
| 9/9/2025 | 4.95 AUD |
| 9/8/2025 | 4.99 AUD |
| 9/5/2025 | 5.11 AUD |
| 9/4/2025 | 5.02 AUD |
| 9/3/2025 | 4.95 AUD |
| 9/2/2025 | 5.01 AUD |
| 9/1/2025 | 5.00 AUD |
| 8/29/2025 | 5.11 AUD |
| 8/28/2025 | 5.03 AUD |
| 8/27/2025 | 5.14 AUD |
| 8/26/2025 | 5.12 AUD |
| 8/25/2025 | 5.17 AUD |
| 8/22/2025 | 5.22 AUD |
| 8/21/2025 | 5.26 AUD |
| 8/20/2025 | 5.23 AUD |
| 8/19/2025 | 5.18 AUD |
| 8/18/2025 | 5.18 AUD |
| 8/15/2025 | 5.17 AUD |
| 8/14/2025 | 5.13 AUD |
| 8/13/2025 | 5.06 AUD |
| 8/12/2025 | 5.07 AUD |
| 8/11/2025 | 4.99 AUD |
| 8/8/2025 | 5.03 AUD |
| 8/7/2025 | 5.14 AUD |
| 8/6/2025 | 5.09 AUD |
| 8/5/2025 | 5.14 AUD |
| 8/4/2025 | 5.04 AUD |
| 8/1/2025 | 5.03 AUD |
| 7/31/2025 | 5.09 AUD |
| 7/30/2025 | 5.09 AUD |
| 7/29/2025 | 5.04 AUD |
| 7/28/2025 | 5.01 AUD |
Medibank Private Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Medibank Private Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEB AUD |
|---|
| REVENUE GROWTH% |
| EBITM AUD |
| EBIT MARGIN% |
| NET INCOMEM AUD |
| NET INCOME GROWTH% |
| DIVIDENDDIV.AUD |
| DIVIDEND GROWTHDIV. GROWTH% |
| SHARESB |
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | 2027e | 2028e | 2029e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.49 | 6.67 | 6.80 | 6.94 | 6.57 | 6.76 | 6.78 | 7.04 | 7.11 | 7.22 | 7.80 | 8.16 | 9.19 | 9.71 | 10.20 | 10.57 |
| 7.99 | 2.84 | 2.02 | 2.00 | -5.36 | 2.97 | 0.19 | 3.82 | 1.04 | 1.59 | 7.96 | 4.60 | 12.73 | 5.66 | 5.02 | 3.65 |
| 317.00 | 396.00 | 546.00 | 628.00 | 598.00 | 616.00 | 453.00 | 709.00 | 782.00 | 243.00 | 713.00 | 730.00 | 855.00 | 937.00 | 990.00 | 975.00 |
| 4.89 | 5.94 | 8.02 | 9.05 | 9.10 | 9.11 | 6.69 | 10.08 | 11.00 | 3.37 | 9.15 | 8.95 | 9.30 | 9.65 | 9.70 | 9.22 |
| 130.00 | 285.00 | 417.00 | 449.00 | 445.00 | 458.00 | 315.00 | 441.00 | 393.00 | 308.00 | 492.00 | 500.00 | 646.00 | 705.00 | 737.00 | 793.00 |
| -43.97 | 119.23 | 46.32 | 7.67 | -0.89 | 2.92 | -31.22 | 40.00 | -10.88 | -21.63 | 59.74 | 1.63 | 29.20 | 9.13 | 4.54 | 7.60 |
| – | 0.08 | 0.16 | 0.17 | 0.16 | 0.12 | 0.17 | 0.18 | 0.19 | 0.21 | 0.24 | 0.26 | 0.24 | 0.25 | 0.26 | – |
| – | – | 100.00 | 6.25 | -5.88 | -25.00 | 41.67 | 5.88 | 5.56 | 10.53 | 14.29 | 8.33 | -7.69 | 4.17 | 4.00 | – |
| 2.75 | 2.75 | 2.75 | 2.75 | 2.75 | 2.75 | 2.75 | 2.75 | 2.75 | 2.75 | 2.75 | 2.75 | 2.75 | 2.75 | 2.75 | 2.75 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Medibank Private generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Medibank Private retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Medibank Private's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Medibank Private has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Medibank Private's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Medibank Private stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Medibank Private Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Medibank Private business model & stock analysis
Medibank Private SWOT Analysis
Strengths
Medibank Private Ltd possesses several strengths that contribute to its success and competitiveness in the market. Firstly, as Australia's largest health insurance provider, the company benefits from a substantial customer base and a strong brand reputation. This offers a significant advantage in attracting and retaining customers.
Additionally, Medibank Private Ltd has established a vast network of healthcare providers, including hospitals, clinics, and specialists. This extensive network provides customers with a wide range of options and accessibility, enhancing customer satisfaction and loyalty.
Furthermore, the company has developed innovative digital platforms and mobile applications that streamline and enhance the customer experience. These technological advancements contribute to increased efficiency and convenience for customers, positioning Medibank Private Ltd as a leader in healthcare technology.
Weaknesses
Despite its strengths, Medibank Private Ltd also faces certain weaknesses that need to be addressed. One weakness is the high competition within the health insurance industry. Numerous competitors offer similar insurance products and services, limiting Medibank Private Ltd's ability to differentiate itself solely based on offerings.
Another weakness is the company's heavy reliance on third-party healthcare providers. This dependency exposes Medibank Private Ltd to fluctuations in pricing and service quality, impacting its ability to control costs and ensure consistent service delivery.
Additionally, the company's focus on digital platforms may pose challenges for certain customer segments who are less technologically inclined or have limited access to internet services. This can potentially exclude these customers from experiencing the full benefits of Medibank Private Ltd's digital offerings.
Opportunities
Medibank Private Ltd can leverage several opportunities to further expand its market presence and profitability. One opportunity lies in the growing demand for personalized and preventive healthcare solutions. By developing and promoting wellness programs, Medibank Private Ltd can tap into this trend and differentiate its offerings from competitors.
Additionally, the aging population in Australia presents an opportunity for Medibank Private Ltd. By tailoring insurance products and services to meet the specific needs of seniors, the company can capture a larger share of this demographic and potentially increase overall market share.
The ongoing digitalization of the healthcare industry also provides opportunities for Medibank Private Ltd. By continuing to invest in technology and enhancing its digital capabilities, the company can improve operational efficiency, expand its reach, and offer innovative solutions to customers.
Threats
Medibank Private Ltd faces several threats that could impact its business operations and market position. One major threat is the potential implementation of government policy changes regarding healthcare regulations and funding. These changes can significantly impact the profitability and viability of private health insurance providers.
Another threat is the increasing cost of healthcare services. As medical costs continue to rise, Medibank Private Ltd may face challenges in managing premium pricing and providing affordable coverage options to customers.
Furthermore, evolving consumer preferences and expectations present a threat to Medibank Private Ltd. Customers are increasingly demanding more personalized and customized insurance solutions, and failure to adapt to these changing preferences could result in a loss of market share to more agile competitors.
Medibank Private Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Medibank Private historical P/E ratio, EBIT multiple, and P/S ratio
Medibank Private annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Medibank Private shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Medibank Private Dividend History
12 years of dividend payments · 6 consecutive increases
Medibank Private dividend history and estimates
Max
Details
Medibank Private dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Current Medibank Private forecasts and price targets in July 2026
Analyst Price Targets 2026| Δ MOM Price Target | 3.92 % |
| Buy | 35.71 % (5) |
| Hold | 57.14 % (8) |
| Sell | 7.14 % (1) |
| 12M Price Target | 5.00 |
| Last Price | 5.12 |
| Currency | AUD |
| 12M Return Potential | -2.38 % |
| LTM Return | 0 % |
Medibank Private Earnings Estimates
| Date | EPS estimate | Revenue Estimate | Quarterly report |
|---|---|---|---|
| 2/21/2024 | 0.09AUD | 3.98 BAUD | 2024 Q2 |
| 8/16/2023 | 0.09AUD | 3.80 BAUD | 2023 Q4 |
| 2/23/2023 | 0.08AUD | 3.80 BAUD | 2023 Q2 |
| 8/18/2022 | 0.07AUD | 3.75 BAUD | 2022 Q4 |
| 2/25/2022 | 0.08AUD | 3.76 BAUD | 2022 Q2 |
| 8/25/2021 | 0.08AUD | 3.62 BAUD | 2021 Q4 |
| 2/24/2021 | 0.08AUD | 3.55 BAUD | 2021 Q2 |
| 8/20/2020 | 0.05AUD | 3.47 BAUD | 2020 Q4 |
| 2/20/2020 | 0.07AUD | 3.42 BAUD | 2020 Q2 |
| 8/22/2019 | 0.10AUD | 3.60 BAUD | 2019 Q4 |
EESG©
Eulerpool ESG Scorecard© for the Medibank Private stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Medibank Private shareholder structure
| % | Name |
|---|---|
10.00877% | |
6.00751% | |
4.85364% | |
3.49884% | |
2.17440% | |
1.60633% |
Medibank Private Executives and Management Board
Mr. David Koczkar
(52)Chief Executive Officer, Executive Director · since 2014
Mr. Mark Rogers
Group Lead - Chief Financial Officer and Group Strategy
Mr. Milosh Milisavljevic
Group Lead - Chief Customer Officer
Mr. Robert Read
Group Lead - Amplar Health
Ms. Kylie Bishop
Group Lead - People, Spaces and Sustainability
Frequently asked questions about Medibank Private
Medibank Private Ltd operates as a leading private health insurance provider in Australia. The company's business model revolves around offering health insurance products and services to a wide range of individuals and families. Medibank Private aims to ensure accessibility, affordability, and quality healthcare for its customers. The company's model focuses on providing comprehensive coverage, including hospital treatment, specialist consultations, and ancillary services. By leveraging its extensive network of healthcare providers and utilizing advanced technological solutions, Medibank Private delivers value-based and customer-centric healthcare solutions. With a strong emphasis on innovation and customer satisfaction, Medibank Private continues to serve as a reliable and trusted health insurance partner.
Medibank Private stock
Medibank Private Peer Group
Medibank Private Ticker
Medibank Private FIGI
All fundamentals and in-depth analysis of Medibank Private
Our stock analysis for Medibank Private stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medibank Private. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.